BLOOD EOSINOPHILIA AND FEV1 - CROSS-SECTIONAL AND LONGITUDINAL ANALYSES

被引:37
作者
FRETTE, C
ANNESI, I
KOROBAEFF, M
NEUKIRCH, F
DORE, MF
KAUFFMANN, F
机构
[1] INSERM,U226,F-75005 PARIS,FRANCE
[2] HOP HOTEL DIEU,F-75181 PARIS 04,FRANCE
来源
AMERICAN REVIEW OF RESPIRATORY DISEASE | 1991年 / 143卷 / 05期
关键词
D O I
10.1164/ajrccm/143.5_Pt_1.987
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A previous cross-sectional analysis of 1980 data from a population of working men in the Paris area has shown a significant relationship of blood eosinophilia to a reduced FEV1 among nonsmokers, remaining after excluding men with a history of asthma. In the present report, we reexamine this relationship, after taking into account asthma, bronchial hyperresponsiveness, and positive skin prick tests, using data collected in 1985 in a subsample of 363 men from the initial population. Blood eosinophilia, defined by 5% or more eosinophils or by 250 or more eosinophils per cubic millimeter appeared to be associated with a lower FEV1, primarily in nonsmokers. A difference of approximately 0.40 L was observed in never-smokers with eosinophilia (greater-than-or-equal-to 5% of eosinophils) compared with those without. This association persisted after exclusion of subjects with atopy, asthma, and bronchial hyperresponsiveness. Longitudinally, no significant association was observed between 1980 eosinophilia and the annual FEV1 decline between 1980 and 1985, even in nonsmokers. The results of our cross-sectional analyses suggest that asthma or asthma-like disorder does not explain the association between eosinophilia and FEV1. The role of eosinophil in respiratory disorders may go beyond its intervention in allergy. Further longitudinal studies are needed to better understand discrepancies between cross-sectional and longitudinal data and whether eosinophilia is a risk factor for chronic air-flow limitation.
引用
收藏
页码:987 / 992
页数:6
相关论文
共 28 条
[1]  
ANNESI I, 1987, B EUR PHYSIOPATH RES, V23, P397
[2]  
ANNESI I, 1989, EUR RESPIR J S5, V2, pS370
[3]   A REEXAMINATION OF RISK-FACTORS FOR VENTILATORY IMPAIRMENT [J].
BURROWS, B ;
KNUDSON, RJ ;
CLINE, MG ;
LEBOWITZ, MD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (04) :829-836
[4]  
BURROWS B, 1986, AM REV RESPIR DIS, V133, P974
[5]   EPIDEMIOLOGIC OBSERVATIONS ON EOSINOPHILIA AND ITS RELATION TO RESPIRATORY DISORDERS [J].
BURROWS, B ;
HASAN, FM ;
BARBEE, RA ;
HALONEN, M ;
LEBOWITZ, MD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1980, 122 (05) :709-719
[6]  
Cotes J. E., 1983, B EUR PHYSIOPATHO S5, V19, P22
[7]   LONGITUDINAL VERSUS CROSS-SECTIONAL VITAL CAPACITY CHANGES AND AFFECTING FACTORS [J].
DONTAS, AS ;
JACOBS, DR ;
CORCONDILAS, A ;
KEYS, A ;
HANNAN, P .
JOURNALS OF GERONTOLOGY, 1984, 39 (04) :430-438
[8]   BLOOD EOSINOPHILS AND EOSINOPHIL-DERIVED PROTEINS IN ALLERGIC-ASTHMA [J].
DURHAM, SR ;
LOEGERING, DA ;
DUNNETTE, S ;
GLEICH, GJ ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (06) :931-936
[9]   THE EOSINOPHIL AND THE PATHOPHYSIOLOGY OF ASTHMA [J].
FRIGAS, E ;
GLEICH, GJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (04) :527-537
[10]  
FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981